Natco Pharma Ltd.
NATCOPHARM Share PricePharmaceuticals & Drugs
₹949.25
13.9 (1.5%)
As on December 4, 2025
Exchange Scrips: BSE524816NSENATCOPHARMISININE987B01026
Market Cap ₹ 17,002 Cr
P/E Ratio 9.01
Dividend Yield 0.32 %
Performance
Market performance
Open939.6
High950.1
Volumes22,68,798
Prev949.25
Low910.5
As on2025-12-04
Historical performance
1 Year High1,505
3 Year High1,639
5 Year High1,639
1 Year Low726.8
3 Year Low502
5 Year Low502
Fundamentals
Company Valuation
Market Cap (₹Cr)
17,002
Face Value (₹)
2
P/E Ratio
9.01
Dividend Yield
0.32 %
Investment Returns
1 Year
-33.6%
3 Years
63.1%
5 Years
3.2%
10 Years
89.9%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 919.53 | Bullish |
| 10-DMA | 894.78 | Bullish |
| 20-DMA | 856.91 | Bullish |
| 50-DMA | 837.26 | Bullish |
| 100-DMA | 875.21 | Bullish |
| 200-DMA | 866.1 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 22 | 22 | 22 | 21 | 21 |
| Foreign Investors | 2 | 2 | 2 | --- | --- |
| Domestic Investors | 20 | 20 | 20 | 21 | 21 |
| Public Investors | 419677 | 429412 | 405200 | 345311 | 302923 |
| Government | 1 | 1 | 1 | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 9.01.
- 3Y Stock Price CAGR of the stock is 17.9.
- The stock has a beta of 1.2.
- In the last financial year, the company had an EBITDA of ₹25505 Million.
- The company generated revenue of ₹44295 Million in the previous financial year.
Natco Pharma Ltd.
949.2513.9 (1.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 658584
No. of Shares: 694 (Approx)
Performance:-34.1%
P/L: ₹-341416
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
